Stizamet ointment for local and external use 3% 10 g

Pharmacotherapeutic group:Tissue reparation stimulator.

ATX code: (D11AX).

Pharmacological properties
Stisamet^® has an anti-inflammatory effect, stimulates skin regeneration and reduces the possibility of suppuration. The drug increases the synthesis of intracellular proteins and nucleic acids, activates the fibroblastic reaction in the dermis. Stisamet ^® also has a photoprotective effect.

Pharmacokinetics
Stisamet^® easily penetrates the skin due to its emulsion base. When applied to the skin, the maximum concentration of methyluracil in the blood is reached after 2 hours, with a half-life of 5.1 hours.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Synopsis

Contraindications

Hypersensitivity, acute and chronic leukemia and other malignant diseases of the hematopoietic system, excess granulation in the wound.

With caution

With caution use in skin diseases accompanied by excessive tissue overgrowths: vegetative vesicular disease, vegetative pyoderma, verrucous form of red squamous lichen, verrucous epidermodysplasia, etc, excessive granulation in wounds and ulcers, acute inflammatory skin diseases and during exacerbation of chronic ones. The drug should also be used with caution on large areas of skin with cholesterol metabolism disorders and severe liver diseases. In radioepithelitis and late vaginal radiation injuries the ointment is used on loose tampons in the form of applications.

Side effects

Similarities